Table 2.

Baseline Characteristics: Total Patient Population

Placebo500 mgCiticoline
Patients, n127267
Age, y, mean 71 70
Sex, % men49%46%
Stroke hemisphere, % left46%48%
Time to treatment, h, mean12.311.7
Weight, kg, mean79.577.7
Baseline NIHSS
Mean12.713.3
4–734%22%P<0.01
8–1120%27%
12–1823%28%
19–3223%23%
Preexisting medical conditions, %
Hypertension72%70%
Previous stroke/TIA37%35%
Heart disease42%40%
Stroke subtype1
Small vessel26%22%
Large vessel43%38%
Cardioembolic24%31%
Thromboembolic 5% 6%
Other 5% 6%
  • 1 TOAST criteria.31